Abstract
Neurodegenerative diseases (NDs) are some of the most debilitating human illnesses. Research over the past 10 years has pro-vided evidence for a common mechanism of neurodegeneration in which the critical event is the brain accumulation of misfolded protein aggregates. Although it is well established that misfolded proteins play an important role in these diseases, the mechanisms by which they cause cellular and tissue dysfunction are still unknown. To understand the molecular basis of NDs and to develop therapeutic strategies against them, numerous transgenic rodent models have been produced, which reproduce some (but not all) of the features of these dis-eases. Importantly, some NDs are not exclusive to human beings, such as transmissible spongiform encephalopathies. Moreover, other diseases which are associated to aging (e.g. Alzheimers disease) could be studied in aged mammals, which could reproduce the human disease in a more natural way. Although the usefulness of transgenic mice is unquestio nable, the information obtained from natural non-transgenic models could be very valuable to fully understand the pathogenesis of these devastating diseases.
Keywords: Prion, protein misfolding, natural model, non-transgenic, Alzheimer's disease, amyloid, Neurodegenerative diseases (NDs), aging, transgenic mice, transmissible spongiform encephalopathies
Current Pharmaceutical Design
Title: Natural Animal Models of Neurodegenerative Protein Misfolding Diseases
Volume: 18 Issue: 8
Author(s): Ines Moreno-Gonzalez and Claudio Soto
Affiliation:
Keywords: Prion, protein misfolding, natural model, non-transgenic, Alzheimer's disease, amyloid, Neurodegenerative diseases (NDs), aging, transgenic mice, transmissible spongiform encephalopathies
Abstract: Neurodegenerative diseases (NDs) are some of the most debilitating human illnesses. Research over the past 10 years has pro-vided evidence for a common mechanism of neurodegeneration in which the critical event is the brain accumulation of misfolded protein aggregates. Although it is well established that misfolded proteins play an important role in these diseases, the mechanisms by which they cause cellular and tissue dysfunction are still unknown. To understand the molecular basis of NDs and to develop therapeutic strategies against them, numerous transgenic rodent models have been produced, which reproduce some (but not all) of the features of these dis-eases. Importantly, some NDs are not exclusive to human beings, such as transmissible spongiform encephalopathies. Moreover, other diseases which are associated to aging (e.g. Alzheimers disease) could be studied in aged mammals, which could reproduce the human disease in a more natural way. Although the usefulness of transgenic mice is unquestio nable, the information obtained from natural non-transgenic models could be very valuable to fully understand the pathogenesis of these devastating diseases.
Export Options
About this article
Cite this article as:
Moreno-Gonzalez Ines and Soto Claudio, Natural Animal Models of Neurodegenerative Protein Misfolding Diseases, Current Pharmaceutical Design 2012; 18 (8) . https://dx.doi.org/10.2174/138161212799315768
DOI https://dx.doi.org/10.2174/138161212799315768 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation
Current Neuropharmacology Increased Neutrophil-to-lymphocyte Ratios are Associated with Greater Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Growth Factors as Therapeutics for Diabetic Neuropathy
Current Drug Targets Tetracyclines: Drugs with Huge Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Targeting PPARalpha in Alzheimer's Disease
Current Alzheimer Research Differential Regulation of microRNAs in Patients with Ischemic Stroke
Current Neurovascular Research Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases
Current Pharmaceutical Design Phytochemicals and Antioxidants: An Evaluation in Understanding the Human Lifeline
Current Nutrition & Food Science Uric Acid and Cu/Zn Superoxide Dismutase: Potential Strategies and Biomarkers in Functional Recovery of Post-Acute Ischemic Stroke Patients after Intensive Neurorehabilitation
Current Neurovascular Research Serotonin and Human Cognitive Performance
Current Pharmaceutical Design Near-Infrared Spectroscopy (NIRS): A Non-Invasive In Vivo Methodology for Analysis of Brain Vascular and Metabolic Activities in Real Time in Rodents
Current Vascular Pharmacology Inflammation and Inflammatory Cell Recruitment in Acute Cerebrovascular Diseases
Current Immunology Reviews (Discontinued) Aporphines and Parkinson’s Disease: Medical Tools for the Future
Current Topics in Medicinal Chemistry Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews Animal Models for Investigating Benign Essential Blepharospasm
Current Neuropharmacology Computational and In-Vitro Validation of Natural Molecules as Potential Acetylcholinesterase Inhibitors and Neuroprotective Agents
Current Alzheimer Research Diabetes and Parkinson’s Disease: Debating the Link Through Ca2+/cAMP Signalling
Current Diabetes Reviews The Clinical Neuroscience of Post Stroke Depression
Current Neuropharmacology Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology Microglia:Neuroprotective and Neurotrophic Cells in the Central Nervous System
Current Drug Targets - Cardiovascular & Hematological Disorders